Trump and Coronavirus Task Force Hold White House Briefing | NBC News
Think. They're. Very positive I thank, them all for being in the call and yesterday, we. Unveil detailed, guidelines for, America's governor's to initiate, a phase safe, and gradual, reopening. Of America, that's. What's happening, the guidelines, provide governor's, with the fact driven and science-based. Metrics. They will need to make the decisions. That are right for, their, own particular state. To. View the guidelines, you can go to the. Website at white house.gov slash. Opening. America so. That's white, house.gov slash. Opening. America. Treasury. Has sent out economic. Relief payments to, more than 80 million Americans, who, have their, direct. Deposit information on, file with the IRS and an. Incredible, success. It has been if. You have not received your check please. Visit, irs.gov. Get, my payment how about that one IRS. Gov, get my payment that, way the IRS can, get you your payment in days and they've. Done a fantastic job, I have to say and you, won't have to wait for, a check in the mail I have some very good news we, sent out 80 million, deposits, and less. Than 1%. Had even. Little. Problems, a couple had minor glitches but it's, substantially. Less than 1%. So out of 80 million deposits. Less. Than 1%, and that gets corrected. Immediately so. Just. Please do as I say you'll get that very quickly very easily, today. I'm also, announcing, that, secretary. Purdue who happens to be right. Next to me handsome man and the. Department, of Agriculture, will be implementing. A 19, billion, dollar, relief. Program, for our great farmers, and ranchers as, they, cope with the fallout of the global. Pandemic. Very honored to be doing this our. Farmers, ranchers we. Have these, are great people great Americans. Never. Complain never, come playing they just do what they have to do. The. Program, will include direct, payments, to farmers as, well as mass, purchases. Of, dairy. Meat, and agricultural. Produce, to. Get that food to the people in, need. The. USDA, will receive another 14 billion dollars in, July that will have funding. To, continue help, are helping. And this will help our farmers and our. Ranches and it's, money. Well deserved, so. Not, only were they targeted at one point by. China and that was over a period. Of time and you saw that happening, and they never complained, but that worked out very well, twelve billion dollars they got and 16 billion dollars they got and now. It's 19, billion I'm just gonna ask. Secretary. Purdue to explain, exactly how we're going to handle it Thank You. Mr.. President you may remember earlier this year you tweeted, a, message, to, our farmers, and ranchers that no matter their circumstances. You pledged to stand behind them, and while, none of us could ever have anticipated this. Type of pandemic, that we're currently in I think, today's announcement. Is proof that you put our you have our farmers backs and that you will continue to do what, it takes to support them and they are very grateful we've, heard a lot recently all of you about our food supply chain I think, America now knows that more than ever the wholesome, foods that our families depend upon and starts. With America's, farmers, and ranchers. America. Agriculture. Has been hard-hit, like most of America, with the coronavirus, and President. Trump is standing with. Our farmers and all Americans to make sure we, all get through this national, emergency, so, today thanks, to your direction and leadership mr.. President USDA is announcing, the coronavirus. Food, assistance program. As you mentioned, this new 19, billion dollar program will, take several immediate, actions, to assist farmers ranchers. And consumers, in response, to the Cova 19, national. Emergency, the, program, is really divided into two parts one, is a. Direct. Payment 16, billion dollar and direct payments to farmers ranchers, and producers who've. Experienced. Unprecedented losses. During, this pandemic, since. We wanted to get the payments out to producers as quickly as possible we decided, to use the funds and the CCC, the current, funds of six and a half million billion, dollars combined. With the 19.5. Of Kovan money rather, than wait for the replenishment, of the, CCC funds, in July based. On industry estimates, of damage mr. president it is becoming apparent that we'll need the additional CCC. Funds, as we continue, to track the, economic, losses, secondly. And this, is really important, as well the USDA, will be purchasing, three, billion dollars, in fresh produce dairy. And meat products, to be distributed, to Americans, in need through, our food bank networks, as well as other community, and faith-based organizations.
Having. To dump milk or plow under vegetables, ready to market, is not, only financially. Distressing, but, it's heartbreaking as, well to those who produce them this, program will not only provide direct, financial relief to our farmers and ranchers mr., president we'll allow for the purchase and distribution of. Our agricultural, abundance in, this country to help our fellow Americans, in need so. In recent weeks we've seen all, of us have seen the heroic. Patriotism, of our food supply chain workers, and, they've shown day in and day out doing. The work conserve fellow. Americans, our farmers. Have been in the fields, planning. And doing what they do every spring to, feed the American people even with the pandemic as we, speak I want, to thank you mr. president for your unwavering support, they want to thank you for your unwavering support, for America's, farmers and ranchers and, I want, to commit to you mr. president and to, the American people at USDA we'll do everything in our power to, implement. This program as quickly and as efficiently as possible, to help our farmers ranchers producers. And consumers during, this great time of need so thank, you very much for having me here today and god bless you god Bless America god, bless america night. Thank. You sunny so. Our, great Secretary. Of Agriculture. Was the governor, of Georgia for eight years and the only reason, he. Isn't. Still there frankly, is that he was term limited and I said let's get him for, agriculture. Do you've done a fantastic job, we, want to thank you very much eight years at Georgia. We. Really appreciate, it great job, even. As we prepare to rebuild, our economy, America. Continues, to wage all-out. Medical. War to defeat the invisible. Enemy to. Date we have conducted more than three. Point seven eight million. Coronavirus. Tests, by far the most of any, country, it's not even close in the, hardest hit areas such as New York and Louisiana, we've also tested, more, people per capita than South Korea Singapore in, every other country, the. United States has, the most. Robust, advanced, an accurate testing system, anywhere in the world, as. Of yesterday we have distributed, nearly six, hundred and sixty thousand, abot IDs. Now, that's. A, an. Incredible, tests called the ID now point of care. Diagnostic. Test and it's. Fantastic. So. It's the hot one from. With this business is it's a hot one till about two days from now because. We do have a saliva test that, just came. Out and. That can be self administered, and it's said. To be fantastic. I want, to thank Abbott, Laboratories, they, have been incredible. I want to thank Roche, they've. Likewise, been incredible. Over, the last several days we've seen a dramatic increase, in the number of tests conducted by hospitals, and academic, institutions. Which. Have now performed, nearly six, hundred thousand tests there's. A tremendous. Amount of, unused, capacity and, the states. Available for governor's to tap we, have tremendous. Unused. Capability. Within those laboratories, and I hope the governors are going to be able to use them the governor's are responsible. For testing and I hope they're going to be able to use this, tremendous. Amount of available. That we have it's. Up to 1 million additional tests, per week. When. You think of that in. The, next few weeks we'll be sending, out 5.5. Million testing, swaps to. The state swabs, can be done easily by the governors themselves. Mostly. It's cotton it's, not a big deal you can get cotton, easily, but if they can't get it, we. Will take care of it. Yesterday. The FDA announced a new, collaboration. With United, Health Group the. Gates Foundation. Quanta. J'en and u.s., cotton to, greatly expand, the supply of essential swabs, including, a new, polyester. Q-tip. Type swab for. The corona, virus testing all, of these actions will help our testing, capability. Continue to grow dramatically. So. We're helping people even. With swabs we get ventilators, where now the the. King of ventilators. We have hundreds. Of thousands, under construction, we. Don't need them ourselves the governors are in great shape if we do we have a great, stockpile, that will immediately send, to the state in need, but. We've handled that situation. Incredibly. Well I hope, people. Understand, it I wish the media would get the word out what we've done in ventilators, is amazing, because they're the. Big expensive, and highly, complex. We're. Speaking to other countries, I spoke to President. Of Mexico today, great gentleman and I. Told him that we, are going to be helping. Him out with ventilators. Helping. Mexico, out and we'll be helping some other countries, too we have a. Lot. Of very high level high quality ventilators. And they're. Here and they're also being manufactured, as we speak, following.
The Announcement of our reopening. Guidelines, there have been some very. Partisan, voices, in the media and politics, who have spread, false. And misleading information about, our testing, capacity it's totally false and misleading demonstrating. A complete, failure to understand, the enormous, scope. Of the testing, capabilities. That we've brought online and we started really from Ground. Zero we. Started, from really. Being very very. Outdated. And obsolete as, a country, from, the past and, I. Will say this if they didn't understand, and it's just really, unfortunately. I hate to say this because we've been getting along very well but it would be false reporting, because they understand, the capability. And, it's. Going to be up to the states to use that capability the, states have local. Points where they can go a governor, can call the mayors and the mayor's can call representatives. And everybody everything is perfect, and that's the way it should work and always should work will. Help New, York and all of the other states get even. Better on their testing, we have to get even, better and some. People think a little bit differently there are areas where you. Have vast. Amounts. Of. Area. Where you. Have very few people and, almost. No people are infected, and those. Places. Will be looked upon differently, by different governors, and, I think you can have a lot of news coming out about that over the next few days I think certain states are going to, come. Online and they're. Going to start the early stages. Of the puzzle that we're putting together and. It's going to be together sooner, rather than later a lot of really incredible things are happening and. At. Some point in the not-too-distant future, we're gonna have our country back and. It's. Gonna be I think really with what we're doing on stimulus, and helping people keep their businesses, together and their lives together and their jobs it's gonna be better.
Than Ever before I hope, so I really do, the. Current conversation, is, reminiscent. Of what, happened on ventilators. You remember that when. Requests, were made far. Beyond what was. Objectively. Needed, we, were hearing. From. A. Certain. State and we were hearing from a lot that they needed far more ventilators. In one case they wanted 40,000. Ventilators. 40,000. It. Turned out that they had plenty and they had a number of about seven. Or eight thousand, and that was plenty we supplied, them with a lot but. That was the right number we we got it just about right and, if. They did need more we're ready to give more but, I think the surge seems to be over, and there, are a lot of Governors just doing a great job and they're working with us but we're all working, together. The. Research, and development that we've. Done at the federal level, has been, absolutely. Incredible, the. Media. Will. Be. Accepting. Of these figures when they get to see, the. End result I think they're going to see it and I think they were already saying it that includes not only ventilators. But beds we built. In. Most cases far more than they even needed. But. We wanted to err on the side of caution this, is what the governor's wanted they wanted a certain amount in, Louisiana. I. Spoke. With the governor had a long talk with him and I said, you think you'll need that final Hospital and, they actually didn't, need it we've built a lot of a lot of beds so I appreciate, it from the governor, and. We saved building, a hospital in. New York we did a I think just a spectacular job, at the Javits Center and. Even. Sending, the ship up became, we. Brought it in to covet but they didn't they. Didn't really need it it, didn't get much use but it was there and ready it, wasn't supposed to be used for that purpose we changed it into that purpose and, it. Was they're ready willing and able same, with Javits, but. They didn't quite need the rooms that we the, beds, that we we. Produced so we produced almost two thousand, nine hundred beds. And I. Think. I'd rather tell you that we, were over prepared, that we were than we were underprepared and that, was a good faith effort by New York I have to say that a very, good faith effort but it's nice that we didn't need that instead. Of needing and it was not very. Occupied, but it was ready to go still, there should something happen but I think, they have it under very good control as you'll. Hear from our, experts, today we've already built. Sufficient. Testing capacity, nationwide. For States to begin their reopening, and I. Think you'll be hearing a lot about reopening, s-- in the coming weeks and months. Most. Excitingly, in the coming weeks. I think you're going, to see some very, very. Dramatic. Steps taken and, very safely we're. Putting safety first. We, may be opening, but we're putting safety first and. When. You look at the the, numbers when you look at the possible, number. Of death deaths, 2.2. Million. People and it could have very well been that it could have been more frankly, I've been looking at numbers where it could have been higher than that. 2.2. Million people dying if, you, figure we lost. 500,000, maybe, 600, thousand of the Civil War, 2.2. Million people a minimum. If we did nothing would have been, 1.6, if you cut that in half you talking about 800,000. 900,000. A million. People dying. But. We did a lot of work and the people of this country were incredible, I have to say and I, think, we're heading to the other category, and that would be if we if we did work and if it was successful they, had between a hundred thousand, and two, hundred and twenty thousand, to two hundred and forty thousand, on, the upside and I.
Think Will be substantially. Hopefully below the hundred number, and. I think right now we're heading it probably, around sixty, maybe. Sixty five thousand, and one, is too many I always say it one is too many it's a horrible, thing that happened to our country, there's a horrible thing that happened to one hundred and eighty four countries, all. Over the world is a horrible, thing and there was no reason for it. It, should never ever happen, again in. A few minutes you'll be hearing from dr., Redfield. Dr. Fauci dr. Burks and Admiral. GWAR to. Explain these facts in in really great detail earlier. This. Week the FDA authorized. Two new antibody, tests which is a very exciting, that, will determine if someone has been previously, infected with the virus, bringing. The total to four authorized. Antibody. Tests, already this. Will help us assess the number of cases that have been asymptomatic. Or. Mildly. Symptomatic. And. Support. Our efforts to get Americans, back to work by showing us. Who might have developed, the. Wonderful. Beautiful immunity. Ultimate. Victory in this war will be made possible by, America's scientific, brilliance, there is nothing, like us there is nobody like us not even close I wish. I could tell you stories what other countries, even powerful, countries, say to, me the, leaders. And. They say it quietly and they say it off the record but they have great respect for what we can do and. Our country is. At. A point a few weeks ago think of it four or five weeks ago we were at. A level that nobody, had ever attained the best job numbers we've ever had the best economy we've ever had, every. Company virtually, was, doing better business. Than ever before the stock market was at. All-time highs, and. Then. One day they said you got to close it up. And. We did the right thing we, saved maybe, millions, of lives by doing it the way we did it but. We're paying a price but that price is very unimportant compared, to the number of lives we're talking about the, NIH and others. Are conducting. Clinical trials, of 35, different therapies, and treatments therapies. Being so exciting, to me because.
That's, Really like if, something, happens you're gonna get better. Reasonably. Quickly and, without. Such a horrible, deal. As some people have to go through to. That end today NIH announced, that it is launching. A public-private. Partnership with, more than a dozen, bio. Pharmaceutical. Companies. They're, HHS. FDA, CDC, and. The European. Medicines. Agency, they're, all working together we're working together with a lot of other countries the. Partnership, will marshal, and, coordinate. The vast resources knowledge. Assets and. Authorities. Of more than a dozen organizations and, agencies to, accelerate. Development of, the most promising, therapies. And vaccines, the vaccines are coming along really really well. Johnson. & Johnson is very well advanced, one. Thing is they have to having. Great great. Success, but we have to test them and it takes a long period of time it. Takes probably. Over, a year unfortunately. But therapies, likewise are coming along, very well therapies, are immediate. When we get that that'll be a big day. We're. Also equipping, our medical, warriors on the front lines in total. We. Have the. Project. Air bridge and the, air bridge has been incredible. The national strategic. Stockpile. And every other channel the federal government is deployed, if. You think about this forty four point five million n95. Masks, nearly, five hundred and twenty four million. Gloves sixty, three point five million surgical, masks, and more. Than 10. Million gowns, and we have. 500. Million masks. Coming, in very soon between. Manufacturing. And orders. 500. Million masks. The, last few months have been among the most challenging. Times in the history of our nation this. Invisible. Enemy. Is. Tough and it's smart, and it's vicious. But. Every day we're getting closer to the, future that we all, have. Been waiting for I. Talked. About the light at the end of the tunnel we. Are getting very very close, to seeing that light shine, very brightly at. The end of that tunnel and it's.
Happening And I want to thank everybody in the room I want to thank I, actually. Want to thank some of the media we've had some fair coverage some really fair coverage and I appreciate it what. I'm going to do is I'm going to introduce a, great. Vice president, Mike Pence and he's going to take over for a little while I'm going to leave and I'm coming right back and we'll take some questions they're going to go over, our. Tremendous, testing. Capabilities. And. Again I'll be right back thank you thank you very much. Thank, You mr. president and good. Afternoon all. Today. As the president just reflected, it remains, a challenging, time in the life of our nation. Because. Of the extraordinary. Efforts, of the American people because of the, strong partnership. The. Federal government has forged with states across the country we're making progress America. Despite. The the, tragic. Loss of more than. 36,000. Americans. According. To our best. Data, reporting. This morning we. Continue to see new, cases low, and steady on the west coast, and. We continue. To see cases, and hospitalizations. Declining. In. The Greater New York City area in, New Orleans and Detroit, and. Elsewhere, this. Is a tribute, first. And foremost to our our health. Care. Doctors. Nurses, all of those working on the front lines but it's, also a great tribute to the American people who have put into, practice, the, social, distancing, the guidelines, the guidance of state and local officials and, we. We. Hope that every, American, is encouraged, by the steady, progress. That, we are making. We're. Continuing to bring at the president's Direction the full resources, of the federal government to bear today the. President, approved a major disaster declaration, for American, Samoa, and now, all 50, states and all territories, are, under major disaster. Declarations. For, the first time. In American. History, at. This present moment, 33,000.
National, Guardsmen are on duty. 5,500. Active, duty military personnel had, been deployed to nine states, including. 716. Medical. Professionals, doctors and nurses, who deployed. Out 14. Different hospitals. Today among. Those were 10 hospitals, in New York City and military. Personnel were also serving, today in hospitals, in Connecticut, Texas, Louisiana. And New Jersey, yesterday. As the president, reflected. We. Unveiled the president's guidelines, for opening up America, again, there. Were two parts at the beginning of those guidelines first the criteria. That. We, hope will guide, governor's. In their decisions, about reopening, their. States on either, a statewide level, or a county, level. And then, also we, outlined, what we believe would be the the, most important, state responsibilities. To have in place before moving. Into a reopening. Plan, for. Phase one the president's, guidelines, you'll recall advise that states, that have a downward trajectory in, cases, over a 14, day. Period of, time and ensure, that they, have proper. Capacity. In their health care facilities, could. Move to, phase, one with. The easing, of some, of the, social distancing. And the criteria, that have been in place but. For states that meet the criteria we. Outline specific, responsibilities. Protecting, workers in critical. Industries, particularly, protecting. The most vulnerable those, who live and work in senior. Care facilities, and we. Also encourage states to have a plan, for, testing. Symptomatic. Individuals. And ensuring, testing, to, our most vulnerable. Populations. As. The president has made clear governor's. Will decide, the time and manner that. Their states, reopen. And we, will look to support them in that effort. But. As we assured the American people yesterday the. President's, direction, our administration, will continue to work with governor's, across, the country to. Ensure that they have the equipment and the supplies and the testing, resources. To, reopen safely. And responsibly. On, the subject of supplies today we issued a letter to our nation's governor summarizing, all the, medical equipment and supplies that have been distributed to their state from. FEMA between. The first of this month and April, 14th, through project, air bridge and through, the commercial, supply network, we'll. Be speaking with our nation's governor's on Monday and detailing. That in from at, that time as of. April 16th, as, the president, reflected briefly, FEMA has coordinated, the delivery of millions, of pieces of medical equipment including. 44. Million, n95. Respirators. 63, million surgical, masks more, than 10,000, ventilators, and of, course deployed more than 8,600. Federal. Federal medical, station, beds on the, subject of testing, resources, we're going to take some time to speak about our. Administration's. Approach in partnership. With States to continue to expand, testing across. The country at this briefing, but. From the very outset of this epidemic. A president. Trump made efforts, to essentially. Reinvent. Testing, in America, a traditional. Testing, in this country that takes place at CDC. Or at state, labs, was. Designed, for basically the kind of diagnostic. Testing. That is routinely, required. But. The president early on in this effort brought together the leading commercial labs in America, we, forged a public and private partnership, and. Six weeks ago we had performed, some. 25,000. Tests and at, this day we have performed, 3.7. Million tests, we, believe that labs and, hospitals, are, now performing, more than a hundred and twenty thousand, tests a day and we've, actually stood up a team from Walter Reed under, the direction of dr. deborah, birx that. Is working around the clock to, identify additional, testing. Capacity across, the country, we. Believe that states could actually more than double, the amount of daily testing that is happening, today. By. Simply, activating. All of the labs and dr. Burks will detail, some of those resources today, and we'll, be going over those very, specifically, with governor's on Monday. We've. Also been promoting, the development of new and innovative tests, we all know about the 15-minute avid, test but. The, FDA is currently, working on an antibody, test that literally could add 20. Million, new tests, to our supply even.
Before The end of April I want, to assure the American people that we're going to continue to work with your governors, and with your state health officials, to scale testing. In the days ahead, but. As you'll. Hear from all, of our experts tonight, our. Best, scientist, and health experts assess. That. States today. Have, enough tests to implement. The, criteria. Of phase, one, if they choose to do so let. Me say that again the. Given. The given. The guidance in. The the president's, new, guidelines, for opening. Up America, again, states. That meet the criteria for, going into phase one and then are. Preparing, the testing, that is contemplated. By going to phase one our, best scientists, and health experts assess, that today, we. Have a sufficient, amount of testing, to, meet the, requirements, of a phase one reopening. If state governors should choose to do that and, you'll hear more detail on that in just a moment at. The president's direction we're going to be presenting an outline of our approach to testing in partnership, with States during. This briefing our, approach will continue, to be locally, executed, state. Managed, and federally, supported dr.. Falchi will give us a brief introduction, to the overall, approach, to testing that is contemplated, to deal with the corona virus dr.. Redfield of CDC, will, describe our, plan to mobilize, CDC, officials, in all 50, states to specifically, monitor. Coronavirus. Corona. Virus incidents, that occur in every state in the Union of, course dr. deborah birx will describe not, only our tests but also the current capability. And the capability, that we could expand. To very readily and Admiral. Gerar of the US Public Health Service will, summarize. Our approach, but. I want to assure the American people that, at. The president's, direction we are going to continue to work every single, day to make sure that our states and communities have, the testing, they need to, reopen at the time and manner of their, choosing and we're, going to work every, day to make sure our states have resources. And the, supplies to. Reopen their, states and reopen, a mirror. In a safe and responsible way with. That dr., pouchy. Thank. You very much mr. vice president so, as the vice president said I'm going to give you a brief introduction. To. Kind. Of answer the question, that we've been asked, a lot in fact we had a, very. Productive. Teleconference. With the Senate, Democratic. Caucus, just, a few hours ago and they, asked a number of questions which, were really reasonable, questions questions. That are on the mind of a lot of different, people and one. Of them was the question that was just posed a moment ago is are. There enough tests, to. Allow us to be able to, go through this first phase in a way that, is protective. Of the health and the safety of, the American people so, I just want to spend a couple of minutes. Clarifying. A few things and maybe providing, some information on a broad. 40,000. Foot which you'll hear some of the more granular. Details. From. My colleagues, who will be following me III, I think they they. Asked, me to give the 40,000. Foot one because I'm not a testing, person I didn't run a testing, lab but. I'm part of a team that is looking at this of how, we can best make sure this happens in the right way so first, of all let me say something that we said before and I apologize, if I'm repeating things that you already know but I think in some, respects it's important, to do that so that people, have clarity, and what we're talking about there.
Are Two general. Types of, tests, even though within each general, type there. Are different subgroups, one. Of them is to actually test, for the infection is a person, infected the. Other and I'll, get back to that in it in a second the other is to test as we, just mentioned if. Someone, has been infected, usually. Someone has been infected, who. Has recovered and as, I'll get to in a moment that you could assume although, we, need to do some more work on that that that person, is actually protected. Against. Subsequent, exposure, and infection, with, an identical organism, so. What, are some of the, pluses, and minuses, of each because, the. Pluses, and minuses, are really going to impact, how we best, use, the test and how. The test actually should. Be used, so. Let's take the, test for whether or not you're, infected. The. Test of whether or not you're infected, is a test, that right now is a call to nucleic acid, test it's not an easy test to do there, are some that are more rapid, there, are some that have a high throughput there, are different groups within. That, the. Good news about that is that it's, a sensitive, and specific test, so. That if you're infected you know you're infected, so that as I'll get to in a moment if you need to, do something with that get that person, put them in care take care of them get them out of circulation that's, important. The. Part about that that I think is often misunderstood. Is. That if you get a test today, like. I did today, it's. Negative if. You get a test today. That. Does not mean that tomorrow, or the next day or the next day or the next day as you. Get exposed, perhaps, from someone, who. May not even know they're infected, that. That means that I'm negative which means if you take, that to its extreme. In. Order to be really sure, you. Would always have to test somebody either. Every, day or every other day or every week oh or what it is to be absolutely certain. That's. An issue, now. The. The problem, that that. III. Talk, about when, when I try and compare, this to. Other situations. With. What testing, means to you I'm, as think most people know have, been involved, in HIV AIDS for 38. Years 39, years from the very first week of HIV. So that's what I do if.
You Get a test, for. HIV and. You. Are negative and, you. Do not practice. Any risk, behaviors. You. Can be guaranteed that, next. Month six. Months one, year from now you. Will be, negative if, you don't have, a risk behavior so there's a big difference there about what testing, actually means so, the point I think you're getting is that although there is clearly. A place for. Needing to test somebody for a given reason a test. Means you're negative now, now. The. Other test is an antibody test a test, that tells you in fact, that you've been infected. That's really, good you're gonna hear a little bit about that from my colleagues, in a moment because, that will give you a broader, view of two, things one what. The penetrance, of the infection, had been and number. Two you can make an assumption though we still need to prove that I mean, we're assuming that if, you're infected and you have anybody you're protected, I don't think that's a reasonable, assumption based, on our experience, with other viruses but. What we want to make sure that we know and these are some of the challenges, what. Is the tighter that, is protective, how, long is the protection, is it one month is it three months is it six months it's a year so. We need to be humble, and modest that we don't know everything about it but it really is an important. Test, the. Other thing is the. Difference between testing and monitoring, out there what's out there, the. Difference, between what. We really needed for for, Phase one is. To be able to identify, isolate. Contact. Trace a very important, part of when, you're putting pulling, back gradually. And slowly on, the mitigation, and, you, have people who might be infected, you want to know they're infected you want to put them in care. That. Is something that we absolutely need. To, do but. There are other ways we I want, to make sure people understand, that not to underestimate. The. Importance, of testing, testing. Is a, part, an important. Part of a, multi-faceted. Way that. We are going to control, and ultimately end, this outbreak, so. Please don't anyone interpreted, that I'm down peasant, testing but, the emphasis, that we've been hearing is essentially. Testing is everything and it isn't it's, the kinds of things that we've been doing the mitigation, strategies, that, are important, part of that, now, just. A couple of things before I hand. It over to my colleagues, no. Doubt no. Doubt that. Early on we, had a problem I have, publicly, said that we had a problem early on there. Was a problem that, had to be corrected and it. Was corrected, it was a problem, that was a technical, problem from, within that. Was corrected, and it, was an issue of. Embracing. The way we have now and should, have the. Private, sector, who clearly, has the capability. Of making, and, providing, tests, at the. Level, that we will need them for any of the things that I've just spoken, about. So. Having. Said that right. Now I totally. Understand, and I'm not alone, my colleagues, understand, that. Although we say there are X number, of tests out there and you're gonna hear from Admiral Jarrah about, that the. Fact is there have been and still. Are, situations. That, are correctable, and will, be corrected, and some of which have been corrected, I know, I get on the phone a lot. With, my colleagues, because believe, it or not, some. Long time ago I was, where they, are in the, hospitals, in the emergency, room looking. At very sick. Individuals. That you need to take care of and I know what it means when someone tells, you hey, you have, what you need and you look around and you say well, maybe you think I have what I need but I don't really have, what I need so, we have to figure out how. Do we close that gap. And there. Are a lot of things that I think we've learned and that we are correcting, and going, to correct. Namely. You, have a situation, where. Tests, are needed and appropriate, and either. People have found there's, no tests, or. There's no reagents, or there's, no swabs or a. Person, needed a test and we're told that. There. Was a restriction, they couldn't get a test these are all the things that I'm telling you you already know because you've. Heard them so. Right now or there's a delay of five, to seven days and, what, does that mean if you want to if you want to get somebody at a circulation, we. Understand, that that existed.
But Upon, careful examination what. You are going to hear, that. Many, of those have, been already corrected, and other, of those will. Be corrected, because, what, I think. People don't appreciate through, no fault of, their own is, that, this is that there are two. Issues. There's, supply. And. Demand. And if. You have a supply, that, can. Meet the demand, but. The supply, is not connected. To demand, then. Supply, demand, falls apart, what, do I mean by that I mean. There is existing. Capacity. That. We have that. For one reason or other maybe. Has not been fully communicated. As to the availability of, that existing, capacity and you're gonna hear about that now, there's. Production. Capacity. That, gets better and better and. Better and. That's. What we're talking about because for what we need now, we. Believe that with, better communications. We'll, be able to make that happen so I know there's gonna be a lot of questions about that I didn't want to go on too long but, let me just finish by saying, given. What I just said and what I believe what you're going to hear, that. For what we need in the first phase if. These things are done correctly what I believe they can we. Will have and there will be enough, tests to allow us to, take this country safely, through phase one. Thank. You mr. vice president I, want. To make a few comments here, first. I want to talk, a little bit about, CDC. Has developed multiple. Systems, to monitor disease outbreaks. I think many of you are familiar for. Example, how we monitor, for foodborne, illness, or how we monitor, for antibiotic, resistance, in, hospitals. Well, we've also developed a. System. To monitor for upper respiratory tract, disease I can. Get the first slide there, this. Is an example because, when we talk about what. We know about this, current, pandemic the. Reality is we know a lot because, we've developed, these monitoring, systems, up, on the slide is a system, that we've developed initially. For, flu, and what. It does as you can see there's. A multiple, different flu seasons, and they. Track them over the course of a year I want. You to look at the red line and, that, happens to be this, year's. Respiratory. Season, and you, see there is a peak. There. Up over the 50 52-week and that. Peak was when we, actually had a peak of influenza, B. This. Year was a little different because after. That, viral. Syndrome came down and you can see it that. Actually we had another peak and that's, when influenza, A was. Active, through our country and, you, can see influenza. A started, to drop but. Then you saw a third peak, that. Peak, was. You. Were looking at the corona virus 19, so. We have systems, all the way down to the county level that. We can see where there's respiratory. Tract. Illness, and, so it's not just just. Taking, a test, it's. Monitoring. These. Systems. That have been developed over the last over decades and. We have multiple, ones we have another one this that, is monitored, in emergency, rooms looking at syndrome, diagnosis. And they show the same thing so. We're well equipped to. Monitor. To see when respiratory, tract, viral. Disease will come, and becomes, a very good surrogate. For. When you can begin to understand, that we need to start looking more ideologically. About. What's going on you can see now in week, 15 we're. Really coming down to the baseline background. In terms of our flu surveillance system from, the overall. Coronavirus. Situation, right now the. Second thing I wanted to say is that, CDC, continues. To enhance the. State's public health capacity. To. Accelerate, their. Ability, as Tony. Talked about it's. Critical, as we, open. America, again, to. Diagnose. Individuals. That. Present with influenza. Like illness. Or. Coronavirus, like illness to diagnose, them, to. Be able to isolate them and to, be able to contact, trace around, them, and then. Diagnose. The contacts, and those. That are, coronavirus. Positive, to, go back and do their contacts, this is the traditional, public health approach which was. Started, in this outbreak in in January, in February and. Was, quite successful when, as I mentioned before through. February. 27th. This country only had 14, cases we. Did that isolation. And that, contact, tracing and. It was very successful but, then when, the virus more exploded, got, beyond the public health capacity but right now CDC, is enhancing, that public health capacity, and. If I can get the second slide, I want, to show you that this is just showing as we sit here today that. CDC, has embedded in these health departments and all of these state at the states across this country more. Than 500, individuals. We. Also have an additional almost, hundred, individuals, that are working on more than twenty coronavirus, outbreaks, that, are going through all these states and. Finally. At the direction of the president, we've, been asked to further enhance this, deployment in each of the states as the vice president said so.
That There's additional public, health personnel, to help accelerate, the state's. Ability to. Basically. Move. Forward, aggressively. And, we assist them so they can operationalize, the. President's, guidelines, to open up America, again so, I just wanted to make those points for, you today. Thank. You. Dr.. Burks. Thank. You mr. vice president and. Thank you dr. Falchi and dr. Redfield for all of that clarity if we can have the next slide I'm. Gonna go back to what dr., Falchi was talking about just to emphasize, those points, about the two types of tests and I'm gonna talk about a third one so, first, we all know about sampling, in the front of your nose to, all of the labs out there and to the providers, you don't have to use the nasal pharyngeal swab, anymore, you can do front of nose sampling. And again, as dr. Falchi, talked about is that as sampling, for the virus, itself. That. Replicates. In your nose and as we know throughout some of the respiratory, tissues. The. Second, test is of course than your immune response, to that infection that's in your nose and so. That's the antibody, test and so, those are the two tests, we want to talk about but I want to come back to something that both dr. Falchi, and dr.. Redfield said, and we, covered yesterday. Testing. Is a part, of the, exquisite. Monitoring. That needs to occur, in, partnership. With CDC, and state and local governments, utilizing. The surveillance, systems, that are available what. We just talked about the flu surveillance system, because we no longer have, flu and the. Syndromic respiratory. System, that is across. The United, States and, you can see it's going back to baseline so that we'll be able to see, at the community, level any deviation, from that baseline, in addition. What we talked about yesterday was, adding that asymptomatic, component. Because. I think you'll see as more and more articles. Come out for surveillance that other and monitoring. That other states, have done higher. And higher antibody, in. Multiple. Individuals. Who, don't remember having a sickness and, that will give us an idea that's our asymptomatic. Monitoring. In these, Sentinel, monitoring. Sites and what, do we talk about yesterday, we talked about nursing, homes we talked about indigenous, people and we talked about vulnerable. People in the inner-city really. Ensuring, that something. That is so small, that can't even be seen on the surveillance, monitoring, will, be able to be seen in the asymptomatic, and so, those are the two tests, that we have one, available now two. That have been approved or three by the FDA. I want. To just leave you with my last concept. On the antibody, tests, antibody. Tests. Have. Different. Specificity. And sensitivities. The. FDA we've, made that they're FDA has been very cautious about the antibody, test because I heat see I know you see reports every day of countries. That have ordered the antibody, test and found, that they were 50, 60, 70, percent faulty, so. We're taking that very seriously, because, you never want to tell someone that they have an antibody and potential, immunity, when they don't and so. Those. Tests, perform, better, when. There's a high prevalence or high incidence, of disease so. We want to work with mayor's, around, the United, States as, those antibody, tests, become available to really, see what it is in first responders. And healthcare workers in the highest prevalence States so. That we can know about the quality, and the real-life real, field, experience.
Of Those assays, because, things can look very good in the lab and then when you take them into the field sometimes they're not as good I've. Learned this lesson repeatedly. In working, around the globe the next slide so. This. Is what we, have asked. Commercial. And diagnostic. Companies to be working, on because. When you talk about multi. Millions, worth, of tests the, way we do this in the United States today for, strep, flew. In for influenza, and, for, malaria is we test for the antigen. Now. We don't, know right now is, bution. Air antigen. In the front of your nose and so, that is the question that's. Scientists, and and companies, are working on right now because, that becomes, a simpler. Test now. The flu test I think, many of you will look it up tonight you, will see that, outside of the flu season because, of the specificity, of the test it. Doesn't work so well so these, are tests, we're working on today that, would be like a screening, test because, if you're positive on, it it's a good test but, it may miss, that. You actually have the flu so. Then you would move into that, what we call the nucleic acid, test so we're trying to build an algorithm. Of, tests, that bring, the full talent, of the science, of the United States into, the reality, of the clinic and so bench, de clinic and so this is what we're working on for the future next slide. So. As I promised, on both the senators, and the governors, this. Is the United States current. Platform. Capacity. Designated. As high and low throughput, and what do I mean by that there's we've, talked about the high throughput platforms. Of Roche and, Abbott and others and then we've talked about the. Gene expert, and other machines, that may be moderate, to lower throughput I want. You to see how it's distributed, through the United States so these are the current testing, platforms, available today, throughout. The United, States for, kovat 19 and, as. You heard, from dr. Falchi. Everything. Has to be working from the, swab. To. The transport, media to. The laboratory, to, really get those, tests, run and the results back to the client the. Next slide so. Then we've looked into all of the testing, capacity from. Those platforms, and this, gives you an idea of, what that capacity is the. Darkest, red you, can see like in Texas, and New York those are in - those are states that have, lots. Of different platforms as you saw on the prior. Slide and, the, ability, if you just add up the platforms. And the potential, for tests of over a million tests per month and so. This is what we're working with each of those states. Unlocking. That full potential, and how are we doing that well, we're caught we're calling on the American, Society of, microbiologist. They have they, work closely with 300, lab directors, around this around, the country we talked with them this morning and the, Walter, Reed team who developed, the entire, HIV. Testing program for the military, 35, years ago I've called them back into service and they're are calling, lab by lab to find out what are the technical difficulties.
To, Bring up all the platforms that exist in your lab is it, swathes is it transport, media is it extraction. And I just really want to thank them they've already worked, through, over. 70 plus of those laboratories, to really understand, and the American Society of, microbiologists. And the academic, societies, of the laboratories, are working, together to. Ensure that all of this potential, can be unlocked next, slide please. We. Talked a little bit yesterday about. New Orleans and, we and the president, talked about how many tests, New Orleans, has done, during. Its outbreak, which you can see now is waning, they've. Done throughout the last month. 27. Tests, per, thousand. New, Orleans and Louisiana uns. So. 27. Per thousand, so, that is a good mark, and that's what. Italy. Has done about 20 per, thousand, so, in evaluating, an, outbreak, and really. To get control, of this outbreak they. Did about 27. Tests per thousand, so using, that as a measure next. Slide, we. Then looked at cross all the states of the United States of America, and looked, for states that had 30. Or more, ability. To do 30 or more tests, per thousand. Of their, inhabitants, in, each state and you, can see that across the country except. For or, a gun. And, Maine. And. I worked. Overseas way. Too long. Thank, you all so. Those, are the three states that we're working on building capacity again. So this is just to give you a perspective, of, how seriously, we're taking, the testing, issue as we've. Described, we've, measured every single platform in, every single state we know exactly where they are by geography by, address, by zip code what. Their capacity is what the cumulative capacity, is what their roadblocks are on non ability, to run all their full capacity and, we're, addressing, those because each one of those is different, and you have to address each of them one, by one with the governor's with the state and local labs and, with all of the hospitals, I have. Not come across one. Laboratory, or, one laboratory director or, one, society, that, doesn't, want to contribute, to. Solving this issue of, testing, and ensuring. That this testing, is available, for everyone there is a strong. Just. As all the Americans, have social, distance, in, behind. Everyone, we don't often talk about the laboratories, will talk about the nurses and doctors on the front line behind, all of them are the laboratory, technicians, and laboratory, directors, who are coming in every day and putting. Things together to ensure that every single person that, needs to be diagnosed, is diagnosed, and, hopefully. You can see from these labs I mean these slides that really, there is capacity. Out there it. Is our job working, with the states and having the state in the leadership, role in the laboratory, directors, in the leadership, role to provide support. To ensure, that all the potential, for testing, in the United States, is brought. To bear I just want to end with these are nucleic acid, tests. There. Will never be the ability, on a. Nucleic, acid, test to do 300, million tests a day or. To test everybody, before they go to work or to school but. There might be with the antigen test and so. That's why there's, a role for nucleic, acid, test there's a role for antibody. Test and there's a role for the future development of, these other key tests, to, bring the full ability to the United, States and so, when. We finish this will be talking to all Americans, because. There's other tests that other Americans should, have and I think this is really brought to light the importance, of diagnosis. And we'll, talk to you further about hepatitis. C and, TB. And other things that we can do to sure every American is healthy, because I think this is really raised the awareness among. All Americans, about. How you do tests for different kinds, in different parts of your disease State and what. Is long-lasting immunity.
And What may be long-lasting, immunity, and what is a nucleic acid, test and what an antigen, test is, and. With. That I'd. Wager our. And. Let me amplify one, point as the Admiral steps forward to. Included. Remarks, about our approach and the efforts we've put under way, governor's. Across the country have been working very closely with us to roll, out the level of testing that we have today and. All. The information we presented, to you is. Going to be. Reviewed, in the days ahead with all of our governor's our objective. Is to connect every, one of America's, governors. And state, health officials, and, to all of the labs that are currently, able to do a corona, virus, and but. As as, as dr., Burke's doctor, pouchy both. Described, we believe today. That. We have the, capacity in the United States, to do a sufficient amount of testing. For, States. To move into phase, one, at. The time and manner that they deemed to be appropriate, with. That I'll allow Admiral, tirado complete. Our briefing, on testing, and we expect the President to return. Thank. You mr. vice president and, thank you to all my really, great, colleagues. Can. I have that my next slide so. I I wanted to start, by. Where we are today and, just to visit where we've come in such a short period of time as everyone. On the stage has said before, our. Testing, right now is well, over 3.7. Eight million, tests that have been completed. And if. You are impressed by bar graphs that's over 1.2, million tests reported, just in the last week. Ambassador. Birx talked, to me a little earlier and she said you know we only do about two, million molecular. Tests, a year, for. HIV, something, that's been done. For developed. For 35 years we're. Now doing twice that number of tests in a, month, for. A disease that has never been known before that, there's never been a test developed before and, that's sort of where we are and wherever it ramped up I also. Want to give you a little idea the, lighter, blue or lighter gray is. Is, our, our. ID now tests, so we. Talked about them a lot because. They are a point-of-care test that can be between, five and fifteen minutes and they, have a very specific role but they're not for everybody if you've, got a screen a few thousand, people for.
Test An hour doesn't, get you there on a machine you have to use some of the larger, higher throughput, items. But they have a very important, role and again, coming into the market at 50,000, per day is really. An important adjunct to us um she. Talked about the gene expert, from Sofia very important we don't talk about that very much but it is one of the backbone, mobile. Point. Of care not, as easy, to do per, se as the. Abbott. But, it is a point of care test that really carries tuberculosis. Screening all through Africa, there. Are these machines you saw that on her slide every. One of the 50 states has. This in over 600 sites, and they've done over 700, thousand tests, just on that relatively. Low throughput. But very important, platform next. Slide please I. Wanted. To give you an idea sort, of how the tests, are distributed, and how they're changing over, time on. The left are the state, public health laboratories, and although. Their numbers are, relatively. Small about. 350,000. The state public health laboratories are absolutely, critical there they're an absolutely, critical core, component, of our testing, not. Only were they there early, in first but. They also do things like support, outbreak, investigations. And nursing homes or, investigations. In certain plants, that have a close proximity with, everyone because of their work environments, they also do testing, on many people who do not have the opportunity to, be tested elsewhere, and they are performing, outstandingly, well a, CLA. I know we hit acronyms, but the American Clinical Laboratory Association. This, is America's, commercial industrial backbone. That, were standing behind the president the vice-president and, and. When I was there a few weeks ago in the Rose Garden this, is the lab core the quest the bio reference, laboratory, Mayo. Sonic. In a RUP and, you'll see they've done almost. 2.3. Million tests, this, is the very large high throughput machines, that. Dr. Burks talks about and and, I want to be clear about about. This group is that it. Doesn't matter where you are I just. Took one of the largest labs and I said map, out for me, where. You are with with it within 10 miles of where you are every. Site in the country and when you do that within. 10 miles of a site of one of these 93. Percent, of the US population is. Covered, these, are truly national, reference, labs that, cover almost, everybody, within the United, States so, if you cannot get a test at your hospital, the, chances, are overwhelming. That you could send this to these labs that, are fully caught up now they. Have no backlog, of tests, they've, ramped, up their production so, their turnaround, time is about 48, hours because you may need to transport it from the. Middle of America out. To a lab, and result that but that's really very very very good the. American Hospital Association also, academic, labs as, the vice president, and the president have said as. More. And more labs. Come online they, are increasing. The amount of testing that are done just at the hospitals, are that kind of academic medical, centers now. Almost at, 600,000. Tests and again, matching, the other slide I had, the. Avid point of care test just to give you a distribution. And that point of care test is, being used very. Importantly. In. Very selective populations, where a point-of-care test is really needed. That could be in some hospitals, where someone needs to know exactly, if, a person is positive, or not to go on a clinical trial or in a nursing home investigation. Or sometimes, to. Get people screened, to go back into the work environment most, people don't need a point-of-care test in fact a point-of-care, test does not cannot. Replace the millions of tests that are here on the other side next, slide. I. Don't know how interested you are in swabs I did not know a whole lot of swabs before, a few weeks ago but. There's. Two points I want to make with with these slides is yes there have been constraining. Elements, and they're constrained for a couple reasons number, one because this is an unprecedented, scale. Up of this type of very. Sophisticated, molecular. Test that. Has never put a demand on a system like we have when. We started out a few weeks ago there's, very, specific one, type of swab only. Get at one place in the u.s. one place in Italy and. We were stuck with that for a while because it's. Not just the quantity it's the quality what, I don't want to do is put a lot of things in the system to make people believe that this is a good test when, it hasn't been validated, by the FDA to say that a positive is a positive and, a negative is, a negative, but, over the past weeks, both.
The Scientific, community, the Gates Foundation, academic. Medical centers the FDA have, really, opened up our ability to not, stick that all the way back in your nasopharynx, but do the anterior, nose and to, greatly broaden, the amount of swab types that are available so we, are really, at a point right now that. Over, the neck by the end of April, we'll put another five million, swabs, in addition to everything that's out there now and, by. The end of May over, 12 million new swabs in the system more, than enough to obtain, the capacity, that we need yes. Slide. For. These molecular tests, you take a swab and you stick it in a test tube and that test tube has to have a specific kind of liquid in it and when, we started it was a viral transport, media a very special, kind of media, the. CDC has to make your own recipe if, you're interested, in cooking you could probably do that but, it has a lot of ingredients that go in there but still very limiting, we've. Worked with many many different laboratories. We've, worked with the FDA so now, PBS, phosphate. Buffered, saline a, kind, of just, laboratory. Grade salt water can, be used for this this, greatly, opens, the ability, to expand. The test to support all the capability, that dr., Burks talks, about and again by, the end of April, we will have put well. Over five million, new tubes, of either viral transport, media or saline into the system I am, going to get to a conclusion here but, this was going to be more of a technical, briefing next. Slide. So. Let's. Talk about, the. Fact that the science, tells, us that. We, have and, will, continue to, have, enough. Tests to. Safely. Go. Into Phase one so. Let me be very granular. About, this we've already heard that, it is beyond, the possibility. To test everyone, in this, country every. Day it's. Not possible, but it's also a bad strategy because. Testing a person now just. Means they're negative, now doctor, foul Chi could be positive tomorrow, because it's brewing in his system right now and we don't know it or that, he contacts, that that's not the way we go about things, the way we go about things, as, dr., Redfield said, just. Think of the weather radar, okay. If the weather radar, is clear. You're. Not going to have a thunderstorm or, tornado when. Something, pops up that's when you've got to go to where the action is or know that your warning system is up so, sort of think of that in the background and I'll go specifically, about that so, that's monitoring, let, me talk about how much testing, we need just. For overall testing, I'm. Just going to give you a number I'm not saying that this is the number that's there but, lets us take a number that, we are going to enter phase one when there are. 200,000, new, cases per month in the United States don't. Get hung up on that it's going to be much less than that but, let's just say 200,000. Cases so. How many tests do we need well, we need to test those 200,000. People to make the diagnosis, right everybody, nod your head about that we, have to do that now.
What's A safe number over, that you, know if everybody I test, has the disease I'm not testing enough right, but, if I test a hundred people to have one person with the disease that's. Probably over testing so, we kind of assumed that a safe number that, really gives us a good idea is, if about one out of ten people are positive, then, we know we're over sampling, in the population, enough that we're getting all the positives, so if there's 200,000. Cases I need about two million tests, okay, now. To go to dr. red Phil's point, each, one of those that are positive, have contacts, that need to be traced in, on average the CDC tells me that, for every positive there are about five contacts. That really need to be traced so. Let's assume that. Those. 200,000. People have five contacts, so now we have an extra million test so. Two million, tests, out there to. Detect the 200,000. Cases an extra. Million out there to, trace those contacts, so we're up to about three million cases if you want to put a fudge factor, say, that's four million tests okay, those. Are generally. Done at the main hospital labs the commercial, labs state. And regional labs all this can be done as well, as some of the labs talked. About by dr. Burks, next. Slide. The. Second, group of testing, fits. Exactly, perfectly. With. The influenza-like surveillance. System that dr., Redfield talked, about this, is the monitoring, this is sort of the radar, the. Weather radar that it would be out there that we're, not testing, people who are symptomatic we. Want to do testing. On people who are asymptomatic, because. You can have asymptomatic carriage, yeah you know you could you could have this virus and shed it and not have symptoms or only mild symptoms so. What is the strategy here, the strategy, here this is an unprecedented, strategy, okay this is this is really unprecedented, but. We're going to do. Between. Three. And five hundred thousand, tests, per week in. The, most vulnerable populations. That, we know that the virus could circulate and what, are they, number one nursing. Home and long-term care facilities, we, know that from the history of this of this virus that, that can circulate and be devastating.
And It could circulate even, in a way that. You don't have symptoms so, we're gonna survey, in a very. Controlled. Way driven, by the CDC, superv